Repligen
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Repligen and other ETFs, options, and stocks.About RGEN
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America.
RGEN Key Statistics
Stock Snapshot
As of today, Repligen(RGEN) shares are valued at $142.82. The company's market cap stands at 8.04B, with a P/E ratio of 5641.25.
As of 2025-11-08, Repligen(RGEN) stock has fluctuated between $139.46 and $144.64. The current price stands at $142.82, placing the stock +2.4% above today's low and -1.3% off the high.
The Repligen(RGEN)'s current trading volume is 623.85K, compared to an average daily volume of 983.16K.
During the past year, Repligen(RGEN) stock moved between $102.97 at its lowest and $182.52 at its peak.
During the past year, Repligen(RGEN) stock moved between $102.97 at its lowest and $182.52 at its peak.
RGEN News
Repligen (RGEN) is back in focus after reporting a one-off net loss of $48.1 million for the twelve months ending September 30, 2025. Despite this significant c...
Repligen Corporation recently announced its third quarter 2025 earnings, reporting revenue of US$188.81 million and net income of US$14.91 million, both marking...
Repligen (RGEN) delivered third-quarter results that grabbed investor attention, with revenues jumping well ahead of forecasts thanks to double-digit growth acr...